文献速递主动脉疾病外周动脉疾病

血管手术后并发症与术后长期阿片类药物使用之间的关联

Association Between Complications after Vascular Surgery and Prolonged Postoperative Opioid Use.
PubMed 文献 · Ann Vasc Surg · 2023-10-05

这项基于人群的队列研究纳入2013至2018年加拿大安大略省11,104例接受下肢开放血运重建或非破裂腹主动脉瘤修复的成人,分析术后长期阿片类药物使用(术后6-12个月填写≥2次阿片类处方)的相关因素。长期使用率在开放下肢血运重建为26.1%、开放腹主动脉瘤修复为13.2%、EVAR为11.6%;既往阿片类使用是最强预测因素。

要点

  • 术后长期阿片类使用率:开放下肢血运重建26.1%、开放腹主动脉瘤修复13.2%、EVAR 11.6%。
  • 既往阿片类使用是最强预测因素,各术式OR分别为AAA 13.27、EVAR 11.24、LER 4.69。
  • 重大并发症仅与开放下肢血运重建患者的长期阿片类使用相关(OR 1.10)。

核心结论

  • 大型血管手术后长期阿片类使用常见,开放或血管内动脉瘤修复患者中超过10%,开放下肢血运重建患者中超过25%。
  • 既往阿片类使用是长期使用的最强预测因素,术后并发症仅与开放下肢血运重建患者的长期使用风险轻度增加相关。
  • 作者认为这些患者人群应作为术后多模式减少阿片类用药的目标人群。

研究设计与样本

  • 基于人群的队列研究,纳入加拿大安大略省2013至2018年所有接受开放下肢血运重建(LER)或非破裂腹主动脉瘤修复(开放AAA和EVAR)的成人。
  • 共纳入11,104例患者,其中开放LER 5,652例、EVAR 3,285例、开放AAA修复2,167例。
  • 长期阿片类使用定义为术后6-12个月填写2次或以上阿片类处方。
  • 采用改良Poisson回归结合广义估计方程分析长期使用的潜在预测因素,以考虑患者在同一医生和机构内的聚集性。

主要发现

  • 既往阿片类使用率:LER 35.4%、AAA 15.8%、EVAR 14.3%。
  • 重大并发症发生率:AAA 59.5%、LER 35.1%、EVAR 21.0%。
  • 术后长期阿片类使用率:LER 26.1%、AAA 13.2%、EVAR 11.6%。
  • 既往阿片类使用对长期使用的OR:AAA 13.27(95%CI 10.63-16.57)、EVAR 11.24(95%CI 9.18-13.75)、LER 4.69(95%CI 4.16-5.29)。
  • 重大并发症与长期阿片类使用的关联:LER OR 1.10(95%CI 1.03-1.19);EVAR OR 0.83(95%CI 0.69-0.99);开放AAA修复 OR 1.11(95%CI 0.95-1.29)。

临床怎么用

  • 作者认为,这些患者人群应作为术后多模式减少阿片类用药方法的目标人群。
  • 原文未据此给出其他临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Few studies have looked at the long-term risk of opioid use following major vascular surgery and no study has investigated the potential association between major complications and prolonged opioid use. We analyzed a population-based database linked to a prescription database to investigate factors associated with prolonged opioid use following major vascular surgery. METHODS: This population-based cohort study included all adults who underwent open lower extremity revascularization (LER) or nonruptured abdominal aortic aneurysm repair (open [AAA] and endovascular [EVAR]) in the province of Ontario, Canada, between 2013 and 2018. Prolonged opioid use was defined as 2 or more opioid prescriptions filled 6-12 months following surgery. Potential predictors of prolonged use were explored using modified Poisson regression with a generalized estimating equation approach to account for the clustering of patients within physicians and institutions. RESULTS: This study included a total of 11,104 patients with 5,652 patients undergoing open LER, 3,285 patients undergoing EVAR, and 2,167 patients undergoing AAA. The rates of prior opioid use were 35.4% for LER, 15.8% for AAA and 14.3% for EVAR. Major complication rates following each procedure were 59.5% for AAA, 35.1% for LER, and 21.0% for EVAR. Following surgery, prolonged opioid use was identified in 26.1% of LER, 13.2% of AAA, and 11.6% of EVAR patients. The strongest predictor of prolonged opioid use was prior use with an odds ratio (OR) of 13.27 (95% CI: 10.63-16.57) for AAA, 11.24 (95% CI: 9.18-13.75) for EVAR, and 4.69 (95% CI: 4.16-5.29) for LER. The occurrence of a major complication was only associated with prolonged opioid use for patients undergoing LER (OR 1.10; 95% CI: 1.03-1.19), while it had a protective effect on patients undergoing EVAR (OR 0.83; 95% CI: 0.69-0.99) and no association for patients undergoing open AAA repair (OR 1.11; 95% CI: 0.95-1.29). Older age was also protective with a reduced rate of prolonged opioid use for every 10 years of age increase: AAA (OR 0.87; 95% CI: 0.77-0.99); EVAR (OR 0.83; 95% CI: 0.76-0.91); and LER (OR 0.91; 95% CI: 0.87-0.94). CONCLUSIONS: Prolonged opioid use is common following major vascular surgery, occurring in over 10% of patients undergoing either open or endovascular aneurysm repair and over 25% of patients undergoing open LER. Prior opioid use is the strongest predictor for prolonged use, while the occurrence of postoperative complications is associated with a slight increased risk of prolonged use in patients undergoing LER. These patient populations should be targeted for multimodal methods of opioid reduction following their procedures.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Dubois L, McClure JA, Vogt K, et al. Association Between Complications after Vascular Surgery and Prolonged Postoperative Opioid Use. Ann Vasc Surg. 2023. PMID: 37802140. doi:10.1016/j.avsg.2023.08.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。